For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses, as well ...
Apply Uracin 20% Cream to affected area(s) twice daily, or as directed by a licensed healthcare practitioner. Rub in until completely absorbed. Apply to diseased or damaged nail(s) twice daily, or as directed by a licensed healthcare practitioner.
www.fda.gov/medwatchUracin 20% Cream is a keratolytic emollient which is a gentle, yet potent, tissue softener for nails and/or skin. Each gram contains 200 mg of urea in a vehicle consisting of the following inactive ingredients : Acrylamide/Sodium Acryloyldimethyltaurate Copolymer, Butyrospermum Parkii (Shea) Butter, Ceteareth-20, Cetearyl Alcohol, Citric Acid, Cocos Nucifera (Coconut) Oil, Dimethicone, Ethylhexylglycerin, Glycerin, Glyceryl Stearate, Helianthus Annuus (Sunflower) Seed Oil, Isohexadecane, PEG-100 Stearate, Phenoxyethanol, Polysorbate 80, Purified Water, Sorbitan Oleate, Xanthan Gum.
Urea is a diamide of carbonic acid with the following chemical structure:
Urea gently dissolves the intracellular matrix which results in loosening of the horny layer of the skin and shedding of scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.
The mechanism of action of topically applied urea is not yet known.
For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses, as well as damaged, ingrown and devitalized nails. Soothes rough and dry skin.
This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.
FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.
KEEP OUT OF REACH OF CHILDREN.
If swallowed, get medical help or contact a Poison Control Center right away.
Avoid contact with eyes, lips and mucous membranes.
This product is to be used as directed by a licensed healthcare practitioner and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a licensed healthcare practitioner.
Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or elsewhere. (See Warnings) for additional precautions.
Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.
Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.
Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.
To report SUSPECTED ADVERSE REACTIONS, contact
PureTek Corporation at
1-877-921-7873 or
FDA at
1-800-FDA-1088 or www.fda.gov/medwatch.
Apply Uracin 20% Cream to affected area(s) twice daily, or as directed by a licensed healthcare practitioner.
Rub in until completely absorbed.
Apply to diseased or damaged nail(s) twice daily, or as directed by a licensed healthcare practitioner.
Uracin™ 20% Cream is supplied in white plastic jars containing 8 oz. (227 g) of cream, NDC 59088-257-16, and 4 oz. (113 g) of cream, NDC 59088-257-08.
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Protect from freezing and excessive heat. Keep container tightly closed.
Manufactured by:
PureTek Corporation
Panorama City, CA 91402
For questions or information
call toll-free:1-
877-921-7873
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0350088157166 | GTIN-13: 0350088157166 EAN-13: 0350088157166 GTIN-12: 350088157166 UPC-A: 350088157166 GTIN storage (14 digits): 00350088157166 | Uracin 8oz.jpg |
| Barcode | EAN-13 | 0359088257081 | GTIN-13: 0359088257081 EAN-13: 0359088257081 GTIN-12: 359088257081 UPC-A: 359088257081 GTIN storage (14 digits): 00359088257081 | Uracin 20 4 oz label jpg.jpg |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59088-257-16 | GM - Gram | 59088-257 | 2d3c687c-27d5-4a15-a929-101ec0aa3737 | 1 | 2026-03-17 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59088-257 | 59088-257-16, 59088-257-08 |
Every source-derived ingredient row is available through these pages.
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 5 | 2026-02-20 | full-release | 2026-05-31 22:08:15 |
| 4 | 2026-02-20 | monthly-update | 2026-06-03 17:57:52 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Uracin 20% | UREA 20% | PureTek Corporation | 4305c057-bd6f-bb58-e063-6294a90abe75 | 2026-02-20 | Warnings, Adverse reactions | 59088-257-16 59088-257 59088025716 4305c057-bd6f-bb58-e063-6294a90abe75 |
Adverse event summaries are temporarily unavailable. Other product information remains available.